Edition:
India

People: ACADIA Pharmaceuticals Inc (ACAD.OQ)

ACAD.OQ on NASDAQ Stock Exchange Global Select Market

56.35USD
9:08pm IST
Change (% chg)

$-0.31 (-0.55%)
Prev Close
$56.66
Open
$57.25
Day's High
$57.25
Day's Low
$55.96
Volume
80,890
Avg. Vol
414,410
52-wk High
$58.67
52-wk Low
$30.02

Schneyer, Mark 

Mr. Mark Schneyer serves as Senior Vice President, Business Development and Chief Business Officer of the Company. Mr. Schneyer joins ACADIA from Pfizer Inc. where he most recently was Vice President, Business Development, for the Upjohn division. Mr. Schneyer joined Pfizer's Worldwide Business Development organization in 2011 and served in various business development positions of increasing responsibility overseeing strategic transactions spanning licensing agreements, product acquisitions and divestitures, strategic collaborations and company acquisitions. Prior to Pfizer, he was an investment banker at Lazard and advised boards of directors and senior management teams in the healthcare sector. Mr. Schneyer earned a Bachelor of Science in economics with a concentration in finance from the Wharton School of the University of Pennsylvania.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Stephen Biggar

319,959

Srdjan Stankovic

5,088,270

Stephen Davis

7,631,250

Elena Ridloff

1,990,870

Austin Kim

1,906,130

Gudarz Davar

--
As Of  31 Dec 2019